Skip to main content
Top
Published in: Endocrine 2/2020

01-02-2020 | Neck Dissection | Original Article

Finger-pressing: a simple and efficient way to stop chyle leak post neck dissection

Authors: Dapeng Xiang, Zhenjie Liu, Tianyao Yang, Binglong Bai, Jingying Zhang, Chengchen Wang, Mao Ye, Zhiyu Li

Published in: Endocrine | Issue 2/2020

Login to get access

Abstract

Purpose

Postoperative chyle leak (CL) is a rare but severe complication after neck dissection. Conservative first-line treatments, such as total parenteral nutrition (TPN), octreotide and pressure dressing, can significantly prolong the hospital stay. Efficient and well-tolerated conservative treatment options are still lacking.

Methods

We have developed a new maneuver to treat CL called “finger-pressing.” A thumb is pressed against the point of leakage between the two muscle heads of the sternocleidomastoid. Finger-pressing continues for about 24 h until CL stops. We used this maneuver to treat six CL patients. Drainage output and duration of hospital stay were compared with another six CL patients treated using the traditional pressure dressing.

Results

The finger-pressing maneuver cured all six CL patients. Most CLs (5/6) could be controlled after about 24 h pressing. Only one high-output CL required 72 h of finger-pressing to stop the leak. All patients had their drainage tubes removed within 3 days after pressing started and all patients tolerated the treatment well. In the control group, the traditional pressure dressing time varied from 2 to 5 days, until the patient was no longer able to cooperate. Three patients underwent a second operation that cured the CL in two cases. The average hospital stay was significantly longer than that in the finger-pressing group (20 vs 9 days, p = 0.037).

Conclusions

Finger-pressing is an efficient and well-tolerated method for treating CL post neck dissection. This maneuver could be a useful adjuvant therapy to traditional methods in treating CL.
Literature
1.
go back to reference V. Merki, J. Pichler, R. Giger, G. Mantokoudis, Chylothorax in thyroid surgery: a very rare case and systematic review of the literature. J. Otolaryngol. Head Neck Surg. 45(1), 52 (2016)CrossRef V. Merki, J. Pichler, R. Giger, G. Mantokoudis, Chylothorax in thyroid surgery: a very rare case and systematic review of the literature. J. Otolaryngol. Head Neck Surg. 45(1), 52 (2016)CrossRef
2.
go back to reference J.A. Glenn, T.W. Yen, G.G. Fareau, A.A. Carr, D.B. Evans, T.S. Wang, Institutional experience with lateral neck dissections for thyroid cancer. Surgery 158(4), 972–978 (2015)CrossRef J.A. Glenn, T.W. Yen, G.G. Fareau, A.A. Carr, D.B. Evans, T.S. Wang, Institutional experience with lateral neck dissections for thyroid cancer. Surgery 158(4), 972–978 (2015)CrossRef
3.
go back to reference R.L. Crumley, J.D. Smith, Postoperative chylous fistula prevention and management. Laryngoscope 86(6), 804–813 (1976)CrossRef R.L. Crumley, J.D. Smith, Postoperative chylous fistula prevention and management. Laryngoscope 86(6), 804–813 (1976)CrossRef
4.
go back to reference R.T. Gregor, Management of chyle fistulization in association with neck dissection. Otolaryngol. Head Neck Surg. 122(3), 434–439 (2000)CrossRef R.T. Gregor, Management of chyle fistulization in association with neck dissection. Otolaryngol. Head Neck Surg. 122(3), 434–439 (2000)CrossRef
5.
go back to reference J.Y. Chan, E.W. Wong, S.K. Ng, C.A. van Hasselt, A.C. Vlantis, Conservative management of postoperative chylous fistula with octreotide and peripheral total parenteral nutrition. Ear Nose Throat J. 96(7), 264–267 (2017)CrossRef J.Y. Chan, E.W. Wong, S.K. Ng, C.A. van Hasselt, A.C. Vlantis, Conservative management of postoperative chylous fistula with octreotide and peripheral total parenteral nutrition. Ear Nose Throat J. 96(7), 264–267 (2017)CrossRef
6.
go back to reference I. Park, N. Her, J.H. Choe, J.S. Kim, J.H. Kim, Management of chyle leakage after thyroidectomy, cervical lymph node dissection, in patients with thyroid cancer. Head Neck 40(1), 7–15 (2018)CrossRef I. Park, N. Her, J.H. Choe, J.S. Kim, J.H. Kim, Management of chyle leakage after thyroidectomy, cervical lymph node dissection, in patients with thyroid cancer. Head Neck 40(1), 7–15 (2018)CrossRef
7.
go back to reference S.W. Delaney, H. Shi, A. Shokrani, U.K. Sinha, Management of chyle leak after head and neck surgery: review of current treatment strategies. Int. J. Otolaryngol. 2017, 8362874 (2017)CrossRef S.W. Delaney, H. Shi, A. Shokrani, U.K. Sinha, Management of chyle leak after head and neck surgery: review of current treatment strategies. Int. J. Otolaryngol. 2017, 8362874 (2017)CrossRef
8.
go back to reference A. Ilczyszyn, H. Ridha, A.J. Durrani, Management of chyle leak post neck dissection: a case report and literature review. J. Plast. Reconstr. Aesthet. Surg. 64(9), e223–e230 (2011)CrossRef A. Ilczyszyn, H. Ridha, A.J. Durrani, Management of chyle leak post neck dissection: a case report and literature review. J. Plast. Reconstr. Aesthet. Surg. 64(9), e223–e230 (2011)CrossRef
9.
go back to reference C.C. Campisi, F. Boccardo, C. Piazza, C. Campisi, Evolution of chylous fistula management after neck dissection. Curr. Opin. Otolaryngol. Head Neck Surg. 21(2), 150–156 (2013)CrossRef C.C. Campisi, F. Boccardo, C. Piazza, C. Campisi, Evolution of chylous fistula management after neck dissection. Curr. Opin. Otolaryngol. Head Neck Surg. 21(2), 150–156 (2013)CrossRef
10.
go back to reference B. Nussenbaum, J.H. Liu, R.J. Sinard, Systematic management of chyle fistula: the southwestern experience and review of the literature. Otolaryngol. Head Neck Surg. 122(1), 31–38 (2000)CrossRef B. Nussenbaum, J.H. Liu, R.J. Sinard, Systematic management of chyle fistula: the southwestern experience and review of the literature. Otolaryngol. Head Neck Surg. 122(1), 31–38 (2000)CrossRef
11.
go back to reference J.I. Ulibarri, Y. Sanz, C. Fuentes, A. Mancha, M. Aramendia, S. Sanchez, Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin. Lancet 336(8709), 258 (1990)CrossRef J.I. Ulibarri, Y. Sanz, C. Fuentes, A. Mancha, M. Aramendia, S. Sanchez, Reduction of lymphorrhagia from ruptured thoracic duct by somatostatin. Lancet 336(8709), 258 (1990)CrossRef
12.
go back to reference A. Coskun, M. Yildirim, Somatostatin in medical management of chyle fistula after neck dissection for papillary thyroid carcinoma. Am. J. Otolaryngol. 31(5), 395–396 (2010)CrossRef A. Coskun, M. Yildirim, Somatostatin in medical management of chyle fistula after neck dissection for papillary thyroid carcinoma. Am. J. Otolaryngol. 31(5), 395–396 (2010)CrossRef
13.
go back to reference F.E. Lucente, T. Diktaban, W. Lawson, H.F. Biller, Chyle fistula management. Otolaryngol. Head Neck Surg. 89(4), 575–578 (1981)CrossRef F.E. Lucente, T. Diktaban, W. Lawson, H.F. Biller, Chyle fistula management. Otolaryngol. Head Neck Surg. 89(4), 575–578 (1981)CrossRef
Metadata
Title
Finger-pressing: a simple and efficient way to stop chyle leak post neck dissection
Authors
Dapeng Xiang
Zhenjie Liu
Tianyao Yang
Binglong Bai
Jingying Zhang
Chengchen Wang
Mao Ye
Zhiyu Li
Publication date
01-02-2020
Publisher
Springer US
Keyword
Neck Dissection
Published in
Endocrine / Issue 2/2020
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-019-02119-0

Other articles of this Issue 2/2020

Endocrine 2/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine